Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,594 | 694 | 99.3% |
| Education | $52.02 | 4 | 0.5% |
| Gift | $18.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,552 | 67 | $0 (2024) |
| Lilly USA, LLC | $1,216 | 110 | $0 (2024) |
| Novo Nordisk Inc | $1,204 | 86 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,120 | 110 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $797.30 | 40 | $0 (2024) |
| PFIZER INC. | $767.61 | 73 | $0 (2024) |
| ABBVIE INC. | $413.55 | 30 | $0 (2023) |
| Amgen Inc. | $361.50 | 24 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $300.68 | 22 | $0 (2021) |
| Astellas Pharma US Inc | $240.87 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $606.81 | 35 | Lilly USA, LLC ($256.66) |
| 2023 | $615.11 | 46 | PFIZER INC. ($171.09) |
| 2022 | $423.94 | 31 | ABBVIE INC. ($160.75) |
| 2021 | $1,172 | 77 | AstraZeneca Pharmaceuticals LP ($195.63) |
| 2020 | $908.76 | 64 | Novo Nordisk Inc ($200.60) |
| 2019 | $1,501 | 129 | Novo Nordisk Inc ($223.68) |
| 2018 | $2,070 | 153 | Novo Nordisk Inc ($559.59) |
| 2017 | $2,366 | 164 | AstraZeneca Pharmaceuticals LP ($630.34) |
All Payment Transactions
699 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes Care | ||||||
| 11/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: VACCINES | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Biological | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Diabetes Care | ||||||
| 06/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: UROLOGY | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: VACCINES | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: DIABETES | ||||||
| 04/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 388 | 450 | $89,875 | $39,892 |
| 2022 | 10 | 366 | 427 | $78,441 | $37,511 |
| 2021 | 10 | 443 | 541 | $74,216 | $35,810 |
| 2020 | 14 | 584 | 723 | $81,706 | $38,649 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 199 | $36,616 | $15,970 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 99 | 99 | $30,789 | $12,148 | 39.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $10,580 | $5,643 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 36 | $4,644 | $2,187 | 47.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 24 | $2,262 | $1,716 | 75.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 26 | 26 | $3,098 | $908.46 | 29.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 26 | $1,066 | $745.68 | 70.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $820.00 | $573.60 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 193 | $35,487 | $15,343 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $20,696 | $9,469 | 45.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $7,406 | $3,901 | 52.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $3,731 | $2,084 | 55.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 27 | $2,397 | $1,841 | 76.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $1,943 | $1,451 | 74.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 19 | $2,451 | $1,276 | 52.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 30 | $1,230 | $816.40 | 66.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 26 | 26 | $1,066 | $710.02 | 66.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 18 | 18 | $2,034 | $619.97 | 30.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 141 | 217 | $37,857 | $16,229 | 42.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 71 | 71 | $14,626 | $8,907 | 60.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 15 | 15 | $4,305 | $2,433 | 56.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 35 | 35 | $3,045 | $2,284 | 75.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 14 | 14 | $4,326 | $2,266 | 52.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 38 | $4,545 | $1,905 | 41.9% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 24 | 24 | $2,712 | $850.32 | 31.4% |
About Dr. Lauren Hopkins, D.O
Dr. Lauren Hopkins, D.O is a Family Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013172683.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Hopkins, D.O has received a total of $9,664 in payments from pharmaceutical and medical device companies, with $606.81 received in 2024. These payments were reported across 699 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($9,594).
As a Medicare-enrolled provider, Hopkins has provided services to 1,781 Medicare beneficiaries, totaling 2,141 services with total Medicare billing of $151,862. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Oklahoma City, OK
- Active Since 07/23/2008
- Last Updated 07/23/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1013172683
Products in Payments
- JARDIANCE (Drug) $930.36
- FARXIGA (Drug) $756.52
- Ozempic (Drug) $610.81
- TRULICITY (Drug) $464.67
- TRELEGY ELLIPTA (Drug) $374.38
- MOUNJARO (Drug) $345.61
- SYMBICORT (Drug) $327.49
- ANORO (Drug) $223.17
- BREO (Drug) $217.73
- PREVNAR 20 (Biological) $180.42
- MYRBETRIQ (Drug) $173.31
- VRAYLAR (Drug) $173.00
- Aimovig (Biological) $170.06
- JANUVIA (Drug) $162.53
- SHINGRIX (Biological) $157.33
- CHANTIX (Drug) $157.30
- Prolia (Biological) $150.35
- SOLIQUA 100/33 (Biological) $140.78
- LINZESS (Drug) $135.09
- Saxenda (Drug) $121.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oklahoma City
Melinda Cail, M.d, M.D
Family Medicine — Payments: $96,253
Dr. Carl Griffin, M.d, M.D
Family Medicine — Payments: $58,692
Dr. John Pittman, M.d, M.D
Family Medicine — Payments: $58,571
Dr. Tyler Phillips, Md, MD
Family Medicine — Payments: $33,490
Terrence Truong, M.d, M.D
Family Medicine — Payments: $31,884
Jonathan Knox, D.o, D.O
Family Medicine — Payments: $23,297